Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Tango Therapeutics, Inc.
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 03, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tickers
TNGX
Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
November 27, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tickers
TNGX
Tango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights
November 06, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tickers
TNGX
Tango Therapeutics Reports Positive TNG462 Clinical Data and Provides Update on PRMT5 Development Program
November 06, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tickers
TNGX
Tango Therapeutics to Participate in Upcoming Investor Conferences
August 28, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tickers
TNGX
Tango Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights
August 07, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tickers
TNGX
Tango Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
June 05, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tickers
TNGX
Tango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
May 08, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tickers
TNGX
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 01, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tickers
TNGX
Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights
March 18, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tickers
TNGX
Tango Therapeutics to Participate in Upcoming Investor Conferences
March 06, 2024
From
Tango Therapeutics, Inc.
Via
Business Wire
Tickers
TNGX
Tango Therapeutics Announces Presentation of Preclinical Data on Lead Program and Discovery Platform in Five Abstracts Accepted at AACR-NCI-EORTC 2021
September 30, 2021
From
Tango Therapeutics, Inc.
Via
Business Wire
Tickers
TNGX
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.